Lanreotide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06791 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 55 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypertrichosis (disease) | KG + DL |
| 2 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 3 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 4 | isolated genetic hair shaft abnormality | KG + DL |
| 5 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 6 | renal-hepatic-pancreatic dysplasia | KG + DL |
| 7 | pulmonary arteriovenous malformation (disease) | KG + DL |
| 8 | polycystic kidney disease 3 with or without polycystic liver disease | KG + DL |
| 9 | genetic alopecia | KG + DL |
| 10 | thoracic malformation | KG + DL |
| 11 | Joubert syndrome with renal defect | KG + DL |
| 12 | adult familial nephronophthisis-spastic quadriparesia syndrome | KG + DL |
| 13 | pulmonary arterial hypertension associated with congenital heart disease | KG + DL |
| 14 | pulmonary arterial hypertension associated with chronic hemolytic anemia | KG + DL |
| 15 | pulmonary arterial hypertension associated with schistosomiasis | KG + DL |
| 16 | pulmonary arterial hypertension associated with HIV infection | KG + DL |
| 17 | pulmonary arterial hypertension associated with connective tissue disease | KG + DL |
| 18 | pulmonary arterial hypertension | KG + DL |
| 19 | karyomegalic interstitial nephritis | KG + DL |
| 20 | syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy | KG + DL |
| 21 | polycystic kidney disease | KG + DL |
| 22 | hypotrichosis simplex of the scalp | KG + DL |
| 23 | congenital hypotrichosis milia | KG + DL |
| 24 | familial isolated trichomegaly | KG + DL |
| 25 | familial generalized lentiginosis | KG + DL |
| 26 | congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome | KG + DL |
| 27 | acromelanosis | KG + DL |
| 28 | diffuse alopecia areata | KG + DL |
| 29 | leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome | KG + DL |
| 30 | gastrocutaneous syndrome | KG + DL |
| 31 | rhabdoid tumor | KG + DL |
| 32 | osteopathia striata-pigmentary dermopathy-white forelock syndrome | KG + DL |
| 33 | Joubert syndrome with oculorenal defect | KG + DL |
| 34 | peripheral nerve schwannoma | KG + DL |
| 35 | Moynahan syndrome | KG + DL |
| 36 | schwannoma of twelfth cranial nerve | KG + DL |
| 37 | sympathetic neurilemmoma | KG + DL |
| 38 | microcystic/reticular schwannoma | KG + DL |
| 39 | trigeminal schwannoma | KG + DL |
| 40 | dermatofibrosarcoma protuberans | KG + DL |
| 41 | Meckel syndrome, | KG + DL |
| 42 | Plasmodium falciparum malaria | KG + DL |
| 43 | alopecia | KG + DL |
| 44 | telangiectasia, hereditary hemorrhagic, | KG + DL |
| 45 | familial rhabdoid tumor | KG + DL |
| 46 | neurocutaneous melanocytosis | KG + DL |
| 47 | non-syndromic brachydactyly | KG + DL |
| 48 | neurofibromatosis | KG + DL |
| 49 | neuroectodermal melanolysosomal disease | KG + DL |
| 50 | persistent fetal circulation syndrome | KG + DL |
(Showing top 50 of 55 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.